Key statistics
As of last trade Anika Therapeutics Inc (AKP:FRA) traded at 16.10, 7.33% above its 52-week low of 15.00, set on Nov 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.10 |
---|---|
High | 16.10 |
Low | 16.10 |
Bid | 16.60 |
Offer | 16.90 |
Previous close | 15.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 14.65m |
Free float | 14.14m |
P/E (TTM) | -- |
Market cap | 255.27m USD |
EPS (TTM) | -6.64 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:05 GMT.
More ▼
- Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
- Anika Announces Third Quarter 2024 Results Conference Call Date
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika to Participate in the Sidoti Virtual Investor Conference
- Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
- Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
- Anika Enters into Cooperation Agreement with Caligan Partners
- Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
- Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
More ▼